Page last updated: 2024-11-02

pilsicainide and Injury, Myocardial Reperfusion

pilsicainide has been researched along with Injury, Myocardial Reperfusion in 2 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niwano, S1
Inuo, K1
Morohoshi, Y1
Nakayama, S1
Yuge, M1
Imaki, R1
Izumi, T1
Liu, JX1
Tanonaka, K1
Ohtsuka, Y1
Sakai, Y1
Takeo, S1

Other Studies

2 other studies available for pilsicainide and Injury, Myocardial Reperfusion

ArticleYear
Mexiletine protects myocardium during acute ischemia by opening sarcolemmal K-ATP channel: studies in closed-chest acute ischemia model in rabbits.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:6

    Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; ATP-Binding Cassette Transporters; Disease Models, A

2004
Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Creatine Kinase; Flecainide; Heart; Lidocai

1993